2 results
Approved WMOCompleted
To evaluate the safety, tolerability and efficacy of 3 doses of vernakalant (oral) (150 mg, 300 mg and 500 mg b.i.d.) administered for up to 90 days in subjects with sustained symptomatic atrial fibrillation (AF duration > 72 hours and &…
Approved WMOPending
The main goal of this study is to evaluate the effectiveness of the NESS L300 on walking skills, as compared to a conventional ankle-foot orthosis, in stroke patients with a drop foot.